ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Aug 6, 2025
2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item
2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase
Read more at globenewswire.com
